|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 375.50 EUR | +1.24% |
|
-1.84% | +2.43% |
| 06-03 | AlphaValue/Baader Reduces Earnings Expectations for L'Oréal After FY25 Results | MT |
| 06-02 | LOREAL : Bernstein reiterates its Neutral rating | ZD |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.88 | 10.36 | 10.31 | 10.02 | 9.4 | |||||
Return on Total Capital | 12.51 | 14.85 | 14.41 | 13.66 | 12.54 | |||||
Return On Equity % | 17.5 | 22.5 | 22 | 20.63 | 18 | |||||
Return on Common Equity | 17.49 | 22.48 | 21.99 | 20.6 | 18 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 73.88 | 72.35 | 73.86 | 74.18 | 74.32 | |||||
SG&A Margin | 51.65 | 49.91 | 50.96 | 51.12 | 51.02 | |||||
EBITDA Margin % | 21.45 | 21.67 | 21.88 | 22.17 | 22.46 | |||||
EBITA Margin % | 19.27 | 19.51 | 19.94 | 20.09 | 20.28 | |||||
EBIT Margin % | 19.05 | 19.47 | 19.77 | 19.95 | 20.16 | |||||
Income From Continuing Operations Margin % | 14.25 | 14.93 | 15.03 | 14.76 | 13.92 | |||||
Net Income Margin % | 14.24 | 14.92 | 15.02 | 14.74 | 13.91 | |||||
Net Avail. For Common Margin % | 14.24 | 14.92 | 15.02 | 14.74 | 13.91 | |||||
Normalized Net Income Margin | 12.53 | 12.81 | 12.81 | 12.73 | 12.76 | |||||
Levered Free Cash Flow Margin | 14.62 | 9.36 | 11 | 12.47 | 13.42 | |||||
Unlevered Free Cash Flow Margin | 14.69 | 9.47 | 11.34 | 13 | 13.94 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.85 | 0.83 | 0.8 | 0.75 | |||||
Fixed Assets Turnover | 6.78 | 7.86 | 7.83 | 7.55 | 7.44 | |||||
Receivables Turnover (Average Receivables) | 8.57 | 8.72 | 8.36 | 8.13 | 7.94 | |||||
Inventory Turnover (Average Inventory) | 2.89 | 2.92 | 2.52 | 2.46 | 2.47 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.73 | 1.02 | 1.1 | 1.13 | 1.44 | |||||
Quick Ratio | 0.46 | 0.61 | 0.7 | 0.72 | 1.06 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.46 | 0.51 | 0.57 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 42.57 | 41.86 | 43.64 | 45 | 45.99 | |||||
Days Outstanding Inventory (Average Inventory) | 126.44 | 125.03 | 145.12 | 148.53 | 147.98 | |||||
Average Days Payable Outstanding | 221.52 | 197.17 | 207.38 | 206.18 | 214.52 | |||||
Cash Conversion Cycle (Average Days) | -52.51 | -30.28 | -18.61 | -12.64 | -20.55 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 26.7 | 20.79 | 29.89 | 25.64 | 34.04 | |||||
Total Debt / Total Capital | 21.08 | 17.21 | 23.01 | 20.4 | 25.4 | |||||
LT Debt/Equity | 5.33 | 15.56 | 21.12 | 20.05 | 26.95 | |||||
Long-Term Debt / Total Capital | 4.21 | 12.88 | 16.26 | 15.96 | 20.1 | |||||
Total Liabilities / Total Assets | 45.15 | 41.96 | 43.92 | 41.2 | 43.38 | |||||
EBIT / Interest Expense | 161.85 | 105.83 | 35.91 | 23.24 | 24.28 | |||||
EBITDA / Interest Expense | 192.97 | 123.85 | 41.62 | 27.09 | 28.37 | |||||
(EBITDA - Capex) / Interest Expense | 164.67 | 104.77 | 35.05 | 22.7 | 24.28 | |||||
Total Debt / EBITDA | 0.86 | 0.65 | 0.92 | 0.84 | 1.15 | |||||
Net Debt / EBITDA | 0.49 | 0.35 | 0.46 | 0.44 | 0.2 | |||||
Total Debt / (EBITDA - Capex) | 1.01 | 0.77 | 1.09 | 1 | 1.34 | |||||
Net Debt / (EBITDA - Capex) | 0.57 | 0.41 | 0.55 | 0.52 | 0.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.35 | 18.5 | 7.64 | 5.6 | 1.3 | |||||
Gross Profit, 1 Yr. Growth % | 16.59 | 16.05 | 9.87 | 6.06 | 1.48 | |||||
EBITDA, 1 Yr. Growth % | 13.58 | 19.69 | 8.67 | 7.49 | 2.62 | |||||
EBITA, 1 Yr. Growth % | 18.44 | 20 | 10.02 | 6.64 | 2.29 | |||||
EBIT, 1 Yr. Growth % | 18.37 | 21.14 | 9.27 | 6.58 | 2.38 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 29 | 24.13 | 8.37 | 3.65 | -4.41 | |||||
Net Income, 1 Yr. Growth % | 29.01 | 24.13 | 8.37 | 3.63 | -4.39 | |||||
Normalized Net Income, 1 Yr. Growth % | 18.1 | 21.21 | 7.61 | 4.93 | 1.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 29.5 | 29.23 | 8.58 | 3.73 | -4.27 | |||||
Accounts Receivable, 1 Yr. Growth % | 14.52 | 18.27 | 7.09 | 10 | -1.81 | |||||
Inventory, 1 Yr. Growth % | 18.35 | 28.81 | 9.88 | 3.3 | -1.87 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.49 | 3.99 | 12 | 7.29 | -1.51 | |||||
Total Assets, 1 Yr. Growth % | -1.36 | 8.91 | 10.7 | 8.67 | 9.7 | |||||
Tangible Book Value, 1 Yr. Growth % | -40.17 | 30.64 | -1.15 | 29.71 | 1.68 | |||||
Common Equity, 1 Yr. Growth % | -18.65 | 15.23 | 6.98 | 13.96 | 5.49 | |||||
Cash From Operations, 1 Yr. Growth % | 4.26 | -6.69 | 21.13 | 8.96 | 4.48 | |||||
Capital Expenditures, 1 Yr. Growth % | 10.57 | 24.93 | 10.83 | 10.28 | -8.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.84 | -24.15 | 26.49 | 20.77 | 8.98 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.27 | -23.6 | 28.86 | 22.11 | 8.53 | |||||
Dividend Per Share, 1 Yr. Growth % | 20 | 25 | 10 | 6.06 | 2.86 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.96 | 16.91 | 12.94 | 6.61 | 3.43 | |||||
Gross Profit, 2 Yr. CAGR % | 4.58 | 16.32 | 12.92 | 7.95 | 3.75 | |||||
EBITDA, 2 Yr. CAGR % | 3.28 | 16.59 | 14.05 | 7.59 | 5.03 | |||||
EBITA, 2 Yr. CAGR % | 5.34 | 19.22 | 14.9 | 7.9 | 4.44 | |||||
EBIT, 2 Yr. CAGR % | 5.41 | 19.75 | 15.05 | 7.92 | 4.46 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 10.7 | 26.54 | 15.98 | 5.98 | -0.46 | |||||
Net Income, 2 Yr. CAGR % | 10.72 | 26.55 | 15.98 | 5.97 | -0.46 | |||||
Normalized Net Income, 2 Yr. CAGR % | 5.26 | 19.64 | 14.21 | 6.26 | 3.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 11.03 | 29.36 | 18.46 | 6.13 | -0.35 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.81 | 16.38 | 12.54 | 8.53 | 3.92 | |||||
Inventory, 2 Yr. CAGR % | 4.13 | 23.47 | 18.97 | 6.54 | 0.68 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.14 | 2.23 | 7.92 | 9.62 | 2.79 | |||||
Total Assets, 2 Yr. CAGR % | -0.91 | 3.65 | 9.8 | 9.68 | 9.19 | |||||
Tangible Book Value, 2 Yr. CAGR % | -26.33 | -11.59 | 13.64 | 13.23 | 14.85 | |||||
Common Equity, 2 Yr. CAGR % | -10.46 | -3.18 | 11.03 | 10.41 | 9.64 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.65 | -1.37 | 6.31 | 14.88 | 6.69 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.54 | 17.53 | 17.67 | 10.55 | 0.22 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 2.8 | -12.11 | -2.05 | 22.39 | 15.19 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 2.52 | -12.04 | -0.78 | 24.24 | 15.58 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.66 | 22.47 | 17.26 | 8.01 | 4.45 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.22 | 8.6 | 13.73 | 10.44 | 4.81 | |||||
Gross Profit, 3 Yr. CAGR % | 6.76 | 8.27 | 14.13 | 10.59 | 5.75 | |||||
EBITDA, 3 Yr. CAGR % | 5.61 | 8.48 | 13.89 | 11.65 | 5.9 | |||||
EBITA, 3 Yr. CAGR % | 7.69 | 10.02 | 16.07 | 11.99 | 6 | |||||
EBIT, 3 Yr. CAGR % | 7.77 | 10.41 | 16.15 | 12.15 | 6.04 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 5.68 | 15.01 | 20.17 | 11.71 | 2.4 | |||||
Net Income, 3 Yr. CAGR % | 5.68 | 15.02 | 20.17 | 11.71 | 2.4 | |||||
Normalized Net Income, 3 Yr. CAGR % | 7.07 | 10.33 | 15.49 | 11.03 | 4.66 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 5.86 | 16.79 | 22.03 | 13.33 | 2.54 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.32 | 5.18 | 13.19 | 11.69 | 4.97 | |||||
Inventory, 3 Yr. CAGR % | 3.92 | 11.78 | 18.76 | 13.5 | 3.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.61 | -3.57 | 5.39 | 7.71 | 5.77 | |||||
Total Assets, 3 Yr. CAGR % | 3.8 | 2.26 | 5.94 | 9.42 | 9.69 | |||||
Tangible Book Value, 3 Yr. CAGR % | -14.04 | -10.83 | -8.24 | 18.76 | 9.24 | |||||
Common Equity, 3 Yr. CAGR % | -4.32 | -2.61 | 0.09 | 12 | 8.75 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.33 | 0.08 | 5.62 | 7.19 | 11.3 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.77 | 2.95 | 15.25 | 15.15 | 3.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.55 | -7.11 | -0.77 | 4.72 | 17.78 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 13.49 | -7.05 | -0.1 | 6.03 | 18.79 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.63 | 15.94 | 18.17 | 13.4 | 6.27 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.32 | 8.01 | 8.86 | 7.8 | 9.49 | |||||
Gross Profit, 5 Yr. CAGR % | 5.97 | 8.2 | 9.18 | 8.14 | 9.86 | |||||
EBITDA, 5 Yr. CAGR % | 4.83 | 7.32 | 8.91 | 8.22 | 10.16 | |||||
EBITA, 5 Yr. CAGR % | 6.76 | 9.8 | 10.52 | 9.28 | 11.21 | |||||
EBIT, 5 Yr. CAGR % | 6.52 | 9.76 | 10.62 | 9.41 | 11.32 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.34 | 8.35 | 9.68 | 11.31 | 11.45 | |||||
Net Income, 5 Yr. CAGR % | 8.16 | 9.77 | 9.68 | 11.31 | 11.45 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.01 | 9.44 | 9.87 | 8.68 | 10.41 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.5 | 9.37 | 10.73 | 12.4 | 12.53 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.4 | 3.92 | 5.04 | 6.51 | 9.39 | |||||
Inventory, 5 Yr. CAGR % | 3.25 | 10.34 | 9.7 | 9.65 | 11.17 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.91 | 6.81 | 8.93 | 1.5 | 4.34 | |||||
Total Assets, 5 Yr. CAGR % | 3.84 | 5.8 | 6.16 | 5.16 | 7.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | -6.3 | -2.42 | -3.88 | -1.89 | 0.38 | |||||
Common Equity, 5 Yr. CAGR % | -0.76 | 1.84 | 1.55 | 2.41 | 3.81 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.42 | 3.85 | 7.52 | 5.76 | 6.05 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.23 | 1.23 | 1 | 5.93 | 8.99 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.67 | 1.95 | 7.03 | 3.95 | 4.99 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.63 | 2.06 | 7.55 | 4.61 | 5.56 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.78 | 11.07 | 11.38 | 12.7 | 12.47 |
- Stock Market
- Equities
- OR Stock
- Financials L'Oréal
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















